chr12-32878512-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001005242.3(PKP2):c.368G>A(p.Trp123*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,460,026 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001005242.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKP2 | NM_001005242.3 | c.368G>A | p.Trp123* | stop_gained | 3/13 | ENST00000340811.9 | NP_001005242.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKP2 | ENST00000340811.9 | c.368G>A | p.Trp123* | stop_gained | 3/13 | 1 | NM_001005242.3 | ENSP00000342800.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460026Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 726108
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Arrhythmogenic right ventricular dysplasia 9 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 17, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 196395). This premature translational stop signal has been observed in individual(s) with arrhythmias and in an individual with arrhythmogenic right ventricular cardiomyopathy (ARVC) and arrhythmogenic right ventricular cardiomyopathy (ARVC) (PMID: 22035158, 25445213). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp123*) in the PKP2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PKP2 are known to be pathogenic (PMID: 15489853, 23911551). - |
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Jul 09, 2019 | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PS1,PM2. - |
Pathogenic, criteria provided, single submitter | clinical testing | Human Genome Sequencing Center Clinical Lab, Baylor College of Medicine | Jun 02, 2017 | The c.368G>A (p.Trp123*) variant in the PKP2 gene has been detected in a family with arrhythmogenic right ventricular cardiomyopathy (ARVC) [PMID 22035158]. The variant segregated within the family; only one carrier individual was clinically asymptomatic. This variant creates a premature stop codon at amino acid position 123 of the PKP2 protein. This variant is thus predicted to result in a loss of function of the protein. This variant has not been observed in the ExAC population database. This variant is thus classified as pathogenic. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 22, 2014 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | May 19, 2021 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 31402444, 22035158, 28600387, 23891399, 25445213, 30847666, 31447099, 32397162, 32372669) - |
Cardiomyopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | May 16, 2019 | This variant changes 1 nucleotide in exon 3 of the PKP2 gene, creating a premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. Computational splicing tools suggest that this variant may not impact RNA splicing. To our knowledge, functional assays have not been performed for this variant. This variant has been reported in three related individuals (PMID: 22035158) and one unrelated individual affected with arrythmogenic right ventricular cardiomyopathy (PMID: 25445213). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of PKP2 function is a known mechanism of disease. Based on available evidence, this variant is classified as Pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The p.W123* pathogenic mutation (also known as c.368G>A), located in coding exon 3 of the PKP2 gene, results from a G to A substitution at nucleotide position 368. This changes the amino acid from a tryptophan to a stop codon within coding exon 3. This variant was detected in a proband with sudden cardiac death and subsequent diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC) and segregated with disease features in the family (Aneq MÅ et al. Scand Cardiovasc J, 2012 Apr;46:72-5). This variant has also been detected in additional individuals with arrhythmia, cardiac arrest and/or confirmed or suspected ARVC (Mellor G et al. Circ Cardiovasc Genet, 2017 Jun;10; van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309; Limongelli G et al. Genes (Basel), 2020 05;11; Lüsebrink E et al. Eur Heart J Case Rep, 2021 Nov;5:ytab417). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at